| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -45,572 | -45,572 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | 12,000 | -16,292 |
| Cash and cash equivalents at beginning of period | 66,656 | - |
| Cash and cash equivalents at end of period | 78,656 | - |
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)